Reid Merryman, MD, on Pre- and Post-Transplant Data for Patients with DLBCL
January 23, 2021

Merryman explains the value of evaluating separate transplant-related questions for patients with relapsed or refractory diffuse large B-cell lymphoma.

Optoacoustic Ultrasound Device for Assessing Breast Lesions Gets Premarket Approval
January 23, 2021

Imagio, a diagnostic tool that uses novel technology to provide real-time information on suspicious lesions in the breast, is OK’d by the FDA.

Neoadjuvant Systemic Therapy Induces Fair Response Rate for High-Risk Retroperitoneal Sarcoma
January 23, 2021

Data published in Cancer the journal found that the response to neoadjuvant therapy in patients with retroperitoneal sarcoma following surgery was fair overall, with data suggesting the potential for disease progression as a predictive tool for patient survival.